Measuring protective efficacy and quantifying the impact of drug resistance: A novel malaria chemoprevention trial design and methodology

Slični predmeti

• Measuring protective efficacy and quantifying the impact of drug resistance: A novel malaria chemoprevention trial design and methodology
  od: Andria Mousa, i dr.
  Izdano: (2024-05-01)
• Impact of dhps mutations on sulfadoxine-pyrimethamine protective efficacy and implications for malaria chemoprevention
  od: Andria Mousa, i dr.
  Izdano: (2025-05-01)
• Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a three-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amodiaquine versus artesunate monotherapy among asymptomatic children 3–5 years of age in Cameroon
  od: Rosario Martinez-Vega, i dr.
  Izdano: (2024-09-01)
• Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a two-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus artesunate monotherapy among asymptomatic children 3–5 years of age in Zambia
  od: Rosario Martinez-Vega, i dr.
  Izdano: (2025-11-01)
• Modeling the Impact of Malaria Chemoprevention with sulphadoxine-pyrimethamine on the spread of Plasmodium falciparum dhps A581G mutation
  od: Nicholaus Mziray, i dr.
  Izdano: (2026-09-01)